WHO: South-East Asia can manufacture future COVID-19 vaccine

World Health Organisation Logo World Health Organisation Logo Foto Screen shot

Tempotimor (Dili) – South-East Asia must play “a lead role in overcoming the ongoing pandemic” by producing a COVID-19 vaccine, the World Health Organisation (WHO) states.

“This region is a vaccine manufacturing powerhouse,” said Dr Poonam Khetrapal Singh, WHO South-East Asia’s regional director. “The manufacturing capacity that exists in our region is of the quality and scale required to produce and roll-out a COVID-19 vaccine globally,” she explained.

Leading manufacturers from India, Indonesia and Thailand discussed timelines and production capacity during a virtual meeting organised by WHO, while regulatory bodies deliberated on adjustments that would be needed in processes to make COVID-19 vaccines available at the earliest. But before this can happen, first pre-clinical and clinical trials, production, licensure, deployment of vaccines and plans for post-marketing surveillance are required.



Globally the WHO has mobilized a broad coalition of scientists, researchers and industry partners to develop and evaluate candidate vaccines for COVID-19. More than 120 potential vaccine candidates have been proposed. The WHO tracks their type and progress. Seven candidate vaccines are already in clinical evaluation and 82 vaccines are in pre-clinical evaluation, WHO says.

Last week WHO launched the ‘Access to COVID-19 Tools Accelerator.’ This brings together key health actors, private sector partners and other stakeholders to accelerate the development and production of health technologies essential in the fight against COVID-19, including vaccines, and to help guarantee equitable access. 

Earlier a UN General Assembly resolution called for all countries to have “equitable, efficient and timely” access to any future vaccines developed to fight COVID-19.

India, Indonesia and Thailand are among the world’s largest vaccine manufacturers.  “Every day, millions of people of all ages are provided life-saving protection by vaccines produced in these three countries,” the WHO states.

“The COVID-19 pandemic is a unique challenge. But I am certain that through collaboration and innovation we can produce a vaccine faster than ever before, while maintaining all standards,” Dr Khetrapal Singh said.


Rate this item
(0 votes)
Last modified on Saturday, 09 May 2020 14:35
Tempo Timor

Ho hakraik an Tempo Timor hato'o komprimentus ba laitor sira katak, Jornal Tempo Timor hahu mosu iha imi le'et atu fasilita informasaun ba imi. Tamba ne'e ami presiza ita boot sira nia tulun atu ekipa jornal ne'e nian bele halao servisu jornalismu ho didiak.

Jornalista Jornal Tempo Timor, bandu atu hetan envelope ka sasan ruma husi fontes informasaun sira.